201 Elliott Avenue West
Seattle , WA 98119
Seattle , WA 98119
News
-
Vertex Pharmaceuticals edged up 0.6% to $400.0 after the company agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, or about $65 per share.
Alpine Immune soared 36% to $64.21.
Apr 11, 2024
Executive/
Director
Links
Price
- Last Close
-
$ 64.54
$ +0.09 0.14 %
Apr 19, 2024
- 52-Week High/Low
- $64.54 - $8.54
- YTD
- 238.6%
- Trading Volume
- 165,084
- Market Cap Full
- $ 3.7B
- Shares Outstanding
-
58.1M
Nov 9, 2023
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | -28.6% | 86.4% | -5% | -16.9% | -35.2% | 5% | 108% |
| Q2 | -99.9% | -99.9% | -99.9% | -4.2% | -34.3% | 4% | -14% | -5.1% | 33.2% | - |
| Q3 | -99.9% | -99.9% | 21.5% | -21.6% | -3.7% | 8% | 18.6% | -15.4% | 11.4% | - |
| Q4 | -99.9% | -99.9% | -4.6% | -37.2% | -3.8% | 43.3% | 29.8% | 2.1% | 67.6% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 39.6% | 32.4% | 12.6% | 1.5% | - | - | - | - | - | - | - | - |
| 2023 | 14.3% | -5.1% | -3.1% | -3% | 33% | 3.2% | 22.1% | -1.6% | -7.3% | -10.6% | 51.4% | 23% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | -67% | 3% | 232% | 10% | -47% | 159% | 239% |
Earnings
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 0.51 | 0.56 | -0.38 | -0.7 | -0.3 | -0.45 | - | -0.28 |
| Q2 | 1.41 | 0.55 | 0.18 | -0.57 | -0.64 | -0.53 | - | - | -0.27 |
| Q3 | 0.39 | 0.48 | 0.19 | -0.88 | -0.62 | - | - | - | -0.24 |
| Q4 | 0.42 | 0.50 | 0.33 | -0.8 | -2.28 | -1.34 | -1.98 | -0.46 | - |
| A | 2.2 | 2 | 1.3 | -2.6 | -2.3 | -1.3 | -2 | -1.7 | -0.79 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 18.6 | 18.6 | 23.9 | 30.3 | 47.8 |
| Jun | 13.8 | 18.6 | 18.6 | 23.9 | 30.3 | 48 |
| Sep | 13.9 | 18.6 | 23.8 | 23.9 | 30.4 | 49.2 |
| Dec | 13.9 | 18.6 | 23.8 | 29.2 | 45.9 | 58.1 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | - | - | - | - | - | |||||||||||||
| Fixed Asset Turnover | 0.8 | 0.4 | 0.3 | 1 | 1 | |||||||||||||
| Total Asset Turnover | 0.1 | 0.1 | 0.1 | - | - | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | - | - | 0.1 | 0.1 | - | |||||||||||||
| Debt – Equity Ratio | - | - | 0.1 | 0.2 | - | |||||||||||||
| Interest Coverage | - | - | 29 | 22 | 19 | |||||||||||||
| Equity multiplier | 0.2 | 0.5 | 0.5 | 0.1 | - | |||||||||||||